Document Detail

The use of oral cyclophosphamide with dexamethasone pulse therapy in the treatment of pemphigus vulgaris.
MedLine Citation:
PMID:  17852639     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Pemphigus vulgaris (PV) is a severe acquired autoimmune disease. During the past 15 years we used dexamethasone pulse therapy (DP) and oral cyclophosphamide for treatment of our patients with PV.
OBJECTIVES: To evaluate the efficacy and side effects of this treatment.
METHOD: The study was a retrospective study. Medical records of 50 known cases of PV, who were treated with dexamethasone pulse therapy and oral cyclophosphamide were evaluated and the patients were re-examined and questioned about their current situations.
RESULTS: Thirty-five females and 15 males were treated, out of which 38 finished the study. At the end of study, 21 patients were in remission, 10 patients were in the healing stage, five patients were partially healed and two patients died. The side effects of this method, especially the adverse effects of cyclophosphamide, were less than previously reported.
CONCLUSION: Dexamethasone pulse therapy and oral cyclophosphamide is an effective regimen with few side effects in the treatment of mild to moderate PV.
Ali Z Momeni; Fariba Iraji; Malih Aminjavaheri; Mahamd Reza Emami; Amir Momeni
Related Documents :
2062329 - Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide...
7803189 - Long-term follow up of patients with common variable immunodeficiency treated with intr...
21814379 - Carbamzepine-induced toxic epidermal necrolysis.
16138939 - Achieving asthma control.
8493629 - Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asth...
10375339 - Treatment of the systemic capillary leak syndrome with terbutaline and theophylline. a ...
2347159 - High tibial osteotomy. a prospective clinical and roentgenographic review.
10872359 - Charnley low-frictional torque arthroplasty of the hip. 20-to-30 year results.
16798999 - A dega-type osteotomy after closure of the triradiate cartilage in non-walking patients...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of dermatological treatment     Volume:  18     ISSN:  0954-6634     ISO Abbreviation:  J Dermatolog Treat     Publication Date:  2007  
Date Detail:
Created Date:  2007-11-05     Completed Date:  2007-11-30     Revised Date:  2014-07-30    
Medline Journal Info:
Nlm Unique ID:  8918133     Medline TA:  J Dermatolog Treat     Country:  England    
Other Details:
Languages:  eng     Pagination:  275-8     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Oral
Cyclophosphamide / administration & dosage*,  adverse effects
Dexamethasone / administration & dosage*,  adverse effects
Drug Therapy, Combination
Glucocorticoids / administration & dosage*,  adverse effects
Immunosuppressive Agents / administration & dosage*,  adverse effects
Infusions, Intravenous
Middle Aged
Pemphigus / drug therapy*,  pathology
Retrospective Studies
Severity of Illness Index
Treatment Outcome
Reg. No./Substance:
0/Glucocorticoids; 0/Immunosuppressive Agents; 7S5I7G3JQL/Dexamethasone; 8N3DW7272P/Cyclophosphamide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The imperatives of leprosy treatment in the pre- and post-global leprosy elimination era: appraisal ...
Next Document:  Coal tar in dermatology.